Recently, at the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Robotrak’s Mona® Adaptive Optics Retinal Imaging System created a sensation, with ophthalmology experts lining up to experience it. By the fourth day of the event, all of Robotrak’s product brochures had been completely distributed. Many ophthalmologists were deeply impressed after trying out the Mona®, and rushed to discuss collaboration before the event concluded. As of this release, five systems have already been pre-ordered. Even in the final moments before the exhibition closed, several top ophthalmology experts made special visits to experience Mona®. AOSLO inventor, Professor Austin Roorda, visited the booth multiple times, stating that with AO entering clinical practice, the Robotrak Mona® would be his sole recommendation.

The recognition from leading experts and the anticipation from peers in the ophthalmology field marked a perfect conclusion to Robotrak’s ARVO 2024, providing powerful momentum for the company to continue moving forward on the global stage.

Conclusion

The launch of the Mona® system has turned the dream of a turn-key AO system—long envisioned by AO imaging pioneer and National Academy of Sciences member, Professor David Williams—into a reality. We believe that the Mona® Adaptive Optics Retinal Imaging System will become a revolutionary product in the AO field, and we are confident that Robotrak’s Mona® will benefit thousands of families and contribute to global eye health, ensuring that everyone has access to a clearer world.